anmelden
OMX Nordic 40
2.620,00
PKT
+7,59
PKT
+0,29
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.10.20 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 14.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 14.10.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 13.10.20 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 13.10.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 13.10.20 | Volvo (B) Outperform | Bernstein Research | |
| 13.10.20 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 13.10.20 | Volvo (B) buy | UBS AG | |
| 13.10.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 12.10.20 | Novo Nordisk Outperform | Credit Suisse Group | |
| 12.10.20 | Ericsson (Telefon L.M.Ericsson) (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.10.20 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 09.10.20 | Nokia buy | UBS AG | |
| 09.10.20 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 09.10.20 | Novo Nordisk Neutral | UBS AG | |
| 09.10.20 | Novo Nordisk Verkaufen | DZ BANK | |
| 09.10.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.10.20 | Nokia buy | Deutsche Bank AG | |
| 08.10.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 07.10.20 | Volvo (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.10.20 | A.P. Moeller - Maersk A-S (B) kaufen | Deutsche Bank AG | |
| 07.10.20 | Volvo (B) buy | Jefferies & Company Inc. | |
| 06.10.20 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 05.10.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 05.10.20 | Volvo (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.10.20 | Hennes Mauritz (H M, H&M) Underperform | Credit Suisse Group | |
| 01.10.20 | Hennes Mauritz (H M, H&M) overweight | JP Morgan Chase & Co. | |
| 01.10.20 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 01.10.20 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 01.10.20 | Hennes Mauritz (H M, H&M) Underperform | Bernstein Research | |
| 01.10.20 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 01.10.20 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 01.10.20 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 01.10.20 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 29.09.20 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.09.20 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.09.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.09.20 | Ericsson (Telefon L.M.Ericsson) (B) Outperform | Credit Suisse Group |